Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas

被引：123

作者：

Kataoka, Keisuke ^{[1
,2
]}

Miyoshi, Hiroaki ^{[3
]}

Sakata, Seiji ^{[4
]}

Dobashi, Akito ^{[4
]}

Couronne, Lucile ^{[5
,6
,7
,8
]}

Kogure, Yasunori ^{[13
]}

Sato, Yasuharu ^{[9
,10
]}

Nishida, Kenji ^{[9
]}

Gion, Yuka ^{[9
]}

Shiraishi, Yuichi ^{[11
]}

Tanaka, Hiroko ^{[11
]}

Chiba, Kenichi ^{[11
]}

Watatani, Yosaku ^{[1
]}

Kakiuchi, Nobuyuki ^{[1
]}

Shiozawa, Yusuke ^{[1
]}

Yoshizato, Tetsuichi ^{[1
]}

Yoshida, Kenichi ^{[1
]}

Makishima, Hideki ^{[1
]}

Sanada, Masashi ^{[12
]}

Onozawa, Masahiro ^{[13
]}

Teshima, Takanori ^{[13
]}

Yoshiki, Yumiko ^{[14
]}

Ishida, Tadao ^{[14
]}

Suzuki, Kenshi ^{[14
]}

Shimada, Kazuyuki ^{[15
]}

Tomita, Akihiro ^{[15
]}

Kato, Motohiro ^{[16
]}

Ota, Yasunori ^{[17
]}

Izutsu, Koji ^{[18
]}

Demachi-Okamura, Ayako ^{[19
]}

Akatsuka, Yoshiki ^{[19
,20
]}

Miyano, Satoru ^{[11
]}

Yoshino, Tadashi ^{[9
]}

Gaulard, Philippe ^{[21
,22
,23
]}

Hermine, Olivier ^{[5
,6
,7
,8
]}

Takeuchi, Kengo ^{[4
]}

Ohshima, Koichi ^{[3
]}

Ogawa, Seishi ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan

[2] Natl Canc Ctr, Div Mol Oncol, Res Inst, Tokyo, Japan

[3] Kurume Univ, Dept Pathol, Sch Med, Kurume, Fukuoka, Japan

[4] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo, Japan

[5] Hop Necker Enfants Malad, AP HP, Dept Hematol, Paris, France

[6] INSERM, UMR 1163, Paris, France

[7] CNRS, ERL 8254, Lab Cellular & Mol Mech Hematol Disorders & Thera, Imagine Inst, Paris, France

[8] Paris Descartes Sorbonne Paris Cite Univ, Paris, France

[9] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan

[10] Okayama Univ, Div Pathophysiol, Grad Sch Hlth Sci, Okayama, Japan

[11] Univ Tokyo, Lab DNA Informat Anal, Ctr Human Genome, Inst Med Sci, Tokyo, Japan

[12] Nagoya Med Ctr, Dept Adv Diag, Clin Res Ctr, Nagoya, Aichi, Japan

[13] Hokkaido Univ, Dept Hematol, Fac Med, Sapporo, Hokkaido, Japan

[14] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan

[15] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan

[16] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan

[17] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan

[18] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[19] Aichi Canc Ctr, Div Immunol, Res Inst, Nagoya, Aichi, Japan

[20] Fujita Hlth Univ, Dept Hematol, Sch Med, Toyoake, Aichi, Japan

[21] Henri Mondor Hosp, AP HP, Dept Pathol, Creteil, France

[22] Inst Mondor Rech Biomed, INSERM, U955, Equipe 9, Creteil, France

[23] Paris Est Univ, Creteil, France

来源：

LEUKEMIA | 2019年 / 33卷 / 07期

关键词：

B-CELL LYMPHOMA; CLASSICAL HODGKIN LYMPHOMA; IMMUNE CHECKPOINT BLOCKADE; GENETIC ALTERATIONS; SOMATIC MUTATIONS; RECURRENT; PD-L1; REARRANGEMENTS; PEMBROLIZUMAB; EXPRESSION;

D O I：

10.1038/s41375-019-0380-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Viral infection induces potent cellular immunity and activated intracellular signaling, which may dictate the driver events involved in immune escape and clonal selection of virus-associated cancers, including Epstein-Barr virus (EBV)-positive lymphomas. Here, we thoroughly interrogated PD-L1/PD-L2-involving somatic aberrations in 384 samples from various lymphoma subtypes using high-throughput sequencing, particularly focusing on virus-associated lymphomas. A high frequency of PD-L1/PD-L2-involving genetic aberrations was observed in EBV-positive lymphomas [33 (22%) of 148 cases], including extranodal NK/T-cell lymphoma (ENKTL, 23%), aggressive NK-cell leukemia (57%), systemic EBV-positive T-cell lymphoproliferative disorder (17%) as well as EBV-positive diffuse large B-cell lymphoma (DLBCL, 19%) and peripheral T-cell lymphoma-not otherwise specified (15%). Predominantly causing a truncation of the 3'-untranslated region, these alterations represented the most prevalent somatic lesions in ENKTL. By contrast, the frequency was much lower in EBV-negative lymphomas regardless of histology type [12 (5%) of 236 cases]. Besides PD-L1/PD-L2 alterations, EBV-positive DLBCL exhibited a genetic profile distinct from EBV-negative one, characterized by frequent TET2 and DNMT3A mutations and the paucity of CD79B, MYD88, CDKN2A, and FAS alterations. Our findings illustrate unique genetic features of EBV-associated lymphomas, also suggesting a potential role of detecting PD-L1/PD-L2-involving lesions for these lymphomas to be effectively targeted by immune checkpoint blockade.

引用

页码：1687 / 1699

页数：13

共 50 条

[21] Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma [J].

Kimura, Hiroshi ;

Okuno, Yusuke ;

Sato, Yoshitaka ;

Watanabe, Takahiro ;

Murata, Takayuki .

FRONTIERS IN MICROBIOLOGY, 2021, 12

[22] Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: Diagnostic overlaps and defining features [J].

Volaric, Ashley K. ;

Fedoriw, Yuri .

HUMAN PATHOLOGY, 2025, 156

[23] Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Portugal [J].

Nogueira, Celia ;

Mota, Marta ;

Gradiz, Rui ;

Cipriano, Maria Augusta ;

Caramelo, Francisco ;

Cruz, Hugo ;

Alarcao, Ana ;

Castro e Sousa, Francisco ;

Oliveira, Fernando ;

Martinho, Fernando ;

Pereira, Joao Moura ;

Figueiredo, Paulo ;

Leitao, Maximino .

INFECTIOUS AGENTS AND CANCER, 2017, 12

[24] Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer [J].

Li, Lin-lin ;

Yu, Ao-yang ;

Zhu, Mei ;

Ma, Lu-yao ;

Cao, Meng-han ;

Liu, Wen-lou ;

Qin, Xiao-bing ;

Gao, Chao ;

Han, Zheng-xiang ;

Wang, Hong-mei .

ARCHIVES OF VIROLOGY, 2024, 169 (05)

[25] The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas [J].

Cader, Fathima Zumla ;

Kearns, Pamela ;

Young, Lawrence ;

Murray, Paul ;

Vockerodt, Martina .

CANCER TREATMENT REVIEWS, 2010, 36 (04) :348-353

[26] Composite Epstein-Barr Virus-associated T-lymphoblastic and Peripheral T-cell Lymphomas: A Clonal Study [J].

Hosoi, Hiroki ;

Mushino, Toshiki ;

Nakashima, Kazutaka ;

Kuriyama, Kodai ;

Tamura, Shinobu ;

Murata, Shogo ;

Imadome, Ken-Ichi ;

Ohshima, Koichi ;

Sonoki, Takashi .

INTERNAL MEDICINE, 2021, 60 (13) :2119-2123

[27] Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas [J].

Okada, Toshiyuki ;

Nakamura, Munetaka ;

Nishikawa, Jun ;

Sakai, Kouhei ;

Zhang, Yibo ;

Saito, Mari ;

Morishige, Akihiro ;

Oga, Atsunori ;

Sasaki, Kosuke ;

Suehiro, Yutaka ;

Hinoda, Yuji ;

Sakaida, Isao .

CANCER SCIENCE, 2013, 104 (10) :1309-1314

[28] Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas [J].

Sakamoto, Kouta ;

Sekizuka, Tsuyoshi ;

Uehara, Taeko ;

Hishima, Tsunekazu ;

Mine, Sohtaro ;

Fukumoto, Hitomi ;

Sato, Yuko ;

Hasegawa, Hideki ;

Kuroda, Makoto ;

Katano, Harutaka .

CANCER MEDICINE, 2017, 6 (03) :605-618

[29] Epstein-Barr virus-associated gastric cancer: disease that requires special approach [J].

Ignatova, Ekaterina ;

Seriak, Daria ;

Fedyanin, Mikhail ;

Tryakin, Alexey ;

Pokataev, Ilya ;

Menshikova, Sofia ;

Vakhabova, Yuliya ;

Smirnova, Ksenia ;

Tjulandin, Sergey ;

Ajani, Jaffer A. .

GASTRIC CANCER, 2020, 23 (06) :951-960

[30] Pathology of Epstein-Barr Virus-Associated Gastric Carcinoma and Its Relationship to Prognosis [J].

Song, Hye-Jong ;

Kim, Kyoung-Mee .

GUT AND LIVER, 2011, 5 (02) :143-148

← 1 2 3 4 5 →